CORPORATE REAL ESTATE MANAGEMENT DURING THE COVID-19 CRISIS AND BEYOND
Bookmark

CORPORATE REAL ESTATE MANAGEMENT DURING THE COVID-19 CRISIS AND BEYOND

CYLAD Consulting has explored how CREM can be utilized as a short-term mitigation lever during the crisis and contribute to a faster business recovery mid-term. We have also hypothesized which structural changes could be instituted in the long run as part of a smart operating model, to secure the health and safety of employees and maintain business resilience.

Category: Tags: ,

Additional information

Industry

Description

Corporate Real Estate Management (CREM) has faced several challenges in recent years. Globalization, international competition, demographic change, innovation, new workplace models, and – at the forefront – digitalization have changed the Corporate Real Estate world significantly. Now, the COVID-19 crisis has disrupted the Real Estate environment with travel bans, office closures, split-teams and a step change in remote work. Regardless of whether or not pandemics break out more regularly in the future, some of the changes made to cope with this unprecedented situation are likely to wholly or partly become permanent features of our work lives. We may even be on the cusp of an evolution in the way we work and how we utilise Real Estate for business.

CYLAD Consulting has explored how CREM can be utilized as a short-term mitigation lever during the crisis and contribute to a faster business recovery mid-term. We have also hypothesized which structural changes could be instituted in the long run as part of a smart operating model, to secure the health and safety of employees and maintain business resilience.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like

  • McKinsey

    In 2007, medical leaders from across the pharmaceutical industry assembled to develop a common understanding of a ten-year vision for Medical Affairs. With five years now past, it is hardly surprising that significant change has occurred in the world in which the pharmaceutical industry operates, especially given the remarkable economic environment and the continued acceleration of technological change.

    Pharma Medical Affairs 2020 and beyond

    $0.00     McKinsey
  • Alix Partner

    New technologies are fundamentally disrupting the business model for consumer products companies around the world. Relationships between manufacturers and retailers – and the consumers they share – are changing, and new business models are emerging. This is a challenge, certainly, but also a tremendous opportunity.

    Achieving Profitable Growth in Consumer Products

    $0.00     Alix Partner
  • EY

    Demographic change, geopolitical turbulence and macroeconomic uncertainty. Disruptive technologies and exploding data volumes. Shifting regulatory requirements. An increasingly complex matrix of competitors, partners and vendors. The financial services industry faces an unprecedented quantum of change — one that will only expand and accelerate.

    Moving from analog to digital

    $0.00     EY

Pin It on Pinterest

Loading..